Clinical Research Study for Healthy Volunteers (Ages 50-64)

Join a new clinical research study evaluating the effectiveness of the investigational COVID-19 vaccine, NVX-CoV2705. This study aims to prevent COVID-19 and gather safety data for healthy adults without underlying conditions linked to severe outcomes.

Overview

This study investigates the non-mRNA vaccine NVX-CoV2705. Participants will receive the most recently approved 2025-2026 COVID-19 vaccination. Compensation is more than $400 for your time and contribution to scientific research.

Participation Requirements

• Healthy adults aged 50 to 64.
• Body Mass Index (BMI) under 31.
• No significant health conditions linked to higher COVID-19 risk (e.g., smoking).
• No COVID-19 vaccine received in the last 90 days.

Study Benefits

• Only one in-person visit (no blood draws) plus three phone follow-ups.
• Receive the current 2025-2026 COVID-19 vaccine.
• Comprehensive health assessment including physical exam and EKG.
• No health insurance or personal medical records required.
• Compensation of more than $400.
• Contribute to evidence-based vaccine research.

How to Apply

To check your preliminary eligibility and for more details:

Call (800) 831-8308 extension 107 and ask for Stephanie. Calls are accepted Tuesday through Saturday, from 9:00 AM to 5:00 PM.